ArticleBlood2016

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Ferran Nadeu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.